Document:

AMENDMENT
TO SHARE EXCHANGE AGREEMENT

 

The
undersigned hereby agree to amend the share exchange agreement among Tropic International Inc., Notox Bioscience Inc. and the
undersigned shareholders of Notox Bioscience Inc. dated June 6, 2016 (the “Share Exchange Agreement”), as follows:

 

	1.	Section
    1.2 of the Share Exchange Agreement is hereby deleted in its entirety and replaced with the following:
	 	 
	 	Schedules.
    The following schedules and appendices are attached to and form part of this Agreement:

 

	 	Schedule
    A	–	The
    Selling Shareholders
	 	Schedule
    B	–	Priveco
    Leases and Other Property Interests
	 	Schedule
    C	–	Priveco
    Intellectual Property
	 	Schedule
    D	–	Priveco
    Material Contracts

 

	 	Appendix
    1	–	Form
    of Assignment Agreement
	 	Appendix
    2	–	Form
    of Consulting Agreement
	 	Appendix
    3	–	Form
    of Stock Restriction Agreement
	 	Appendix
    4	–	Form
    of Termination Agreement

 

	2.	Section
    3.19     of the Share Exchange Agreement is hereby amended by deleting the phrase “Schedule D” and replacing it
    with “Schedule     B”.
	 	 
	3.	Section
    3.20     of the Share Exchange Agreement is hereby amended by deleting the phrase “Schedule E” and replacing it
    with “Schedule     D.”
	 	 
	4.	Section
    6 of the Share Exchange Agreement is hereby amended by adding the following Section 6.10:
	 	 
	 	Assignment
    Fee. In consideration for inducing Zoran Holding Corp. to enter into the Assignment Agreement, Pubco shall pay an aggregate
    of $1,000,000 to Zoran K Corporation following the Closing Date in the form of a one-time assignment fee. Such fee shall be
    payable according to the following schedule:

 

	 	(a)	$50,000
    per calendar month beginning on October 1, 2016; and
	 	 	 
	 	(b)	upon
    the completion of any equity financing pursuant to which Pubco raises gross proceeds of at least $1,000,000, the balance of
    the fee, less any amounts already paid by Pubco to Zoran K Corporation under Section 6.10(a).

 

	5.	Section
    6 of the Share Exchange Agreement is hereby amended by adding the following Section 6.11:
	 	 
	 	Operations.
    Subject to Section 6.10, Pubco shall use the proceeds of any equity financing that may be completed after the Closing Date
    for substantially the following purposes:

 

	 	(a)	developing
    and commercializing the Licensed Technology (as defined in the Assignment Agreement);
	 	 	 
	 	(b)	carrying
    out Priveco’s obligations under the Assignment Agreement, which, for clarity are identical to the obligations of Zoran
    Holding Corp. under an exclusive license agreement with The Cleveland Clinic Foundation (the ”Clinic”)
    dated December 1, 2012, as amended on July 30, 2013 (together, the ”License Agreement”);
    and

 

    	 

    	-2-

    

 

	 	(c)	paying
    general working capital expenses, including but not limited to:

 

	 	 	(i)	engaging
    one or more parties to submit applications to the United States Food and Drug Administration (the “FDA”)
    on Priveco’s behalf and paying any associated required deposits;
	 	 	 	 
	 	 	(ii)	signing
    one or more agreements with FDA-approved third parties to design, test and manufacture all components required to commercialize
    the Licensed Technology;
	 	 	 	 
	 	 	(iii)	paying
    all required amounts to the Clinic under the License Agreement, to a maximum of $1,000,000;
	 	 	 	 
	 	 	(iv)	setting
    aside and paying, as necessary, all amounts required to conduct human testing of the foregoing components if the same is required
    by the FDA; and
	 	 	 	 
	 	 	(v)	filing
    any documents with the FDA required under the License Agreement on or before November 30, 2017.

 

	6.	Section
    1.1 of the Share Exchange Agreement is hereby amended by adding the terms “Clinic”, “FDA”
    and “License Agreement” as Sections 1.1(jj), 1.1(kk) and 1.1(ll), together with the phrase “has the
    meaning ascribed to that term in Section 6.11” following each such term.

 

All
other provisions of the Share Exchange Agreement remain unchanged, and except as amended hereby the Share Exchange Agreement remains
in full force and effect.

 

This
amendment shall be governed by and construed in accordance with the laws of the State of Nevada applicable to contracts made and
to be performed therein.

 

This
amendment may be executed and delivered in counterparts and by electronic transmission, each of which shall be deemed an original,
and all of which together shall constitute one and the same instrument.

 

This
amendment is effective as of November 23, 2016.

 

    	 

    	-3-

    

 

	TROPIC INTERNATIONAL INC.	 	NOTOX BIOSCIENCE INC.
	 	 	 	 
	Per:	/s/ John Marmora	 	Per:	/s/ Zoran Konevic
	Name:	John Marmora	 	Name:	Zoran Konevic
	Title:	President	 	Title:	President

 

	 	 	ZORAN K CORPORATION
	 	 	 
	/s/ Gerry Racicot	 	Per:	/s/ Zoran Konevic
	GERRY RACICOT	 	Name:	Zoran Konevic
	 	 	Title:	CEOSHARE PURCHASE AGREEMENT

 

This Agreement made as of the
29th day of  December 2016 (“Agreement”), by and between Thomas DeNunzio, with an address at 780
Reservoir Avenue, #123, Cranston, R.I. 02910 ("Seller"), and Photozou Co., Ltd with an address at 2-24-13-904,
Kamiosaki, Shinagawa-ku, Tokyo, 141-0021, Japan ("Purchaser").

W I T N E S S E T H:

 

WHEREAS,
Seller is the record owner and holder of 8,000,000 Common Shares, par value $.0001 par value (the “Shares”), of EXQUISITE
ACQUISITION, INC., a Delaware corporation ("Corporation”), which Corporation has 8,000,000 shares of restricted
common stock issued and outstanding as of the date of this Agreement. The Corporation has filed an S-1 registration statement with
the Securities and Exchange Commission with an effective date of August 19, 2016. The CIK No. is 0001627469. None of the Seller’s
shares are registered and therefore are restricted securities.

 

WHEREAS,
Purchaser desire to purchase 8,000,000 restricted Shares from Seller, which constitutes 100% of the Corporation’s
issued and outstanding Shares as of the date of this Agreement and Seller desires to sell such Shares upon the terms and conditions
hereinafter set forth;

 

NOW, THEREFORE,
in consideration of the foregoing and of the mutual covenants and agreements contained in this Agreement, and necessary to consummate
the purchase and sale of the Seller’s Shares, it is hereby agreed, as follows:

 

		1.	PURCHASE AND SALE
OF SHARES. Subject to the terms and conditions of this Agreement, Purchaser agrees to purchase at the Closing and the Seller
agrees to sell to Purchaser at the Closing, 8,000,000 of Seller’s Shares for a purchase price of One Hundred Thousand U.S.
dollars and no cents ($100,000.00), (the “Purchase Price”). Purchaser agrees to wire transfer to an account to be designated
by Seller, the sum of One Hundred Thousand U.S. dollars and no cents ($100,000.00) to Seller at Closing. Purchaser will wire funds
and provide Seller with proof of payment within 24 hours of Closing.

 

2. EVENT OF DEFAULT.
If, in the event Purchaser shall fail to make and evidence to Seller payment of the purchase price pursuant to paragraphs No. 1.,
then this agreement will automatically become null and void without any further notification to Purchaser notwithstanding that
Purchaser in his sole discretion may extend the time for performance of this Agreement if requested by Seller in writing. 

 

If, in the event Purchaser
fails to tender the said purchase price per the terms and conditions set forth in paragraph No. 3., then this Agreement will automatically
become null and void. Seller in his sole discretion may extend the time for performance of this Agreement if requested by Purchaser
in writing. Purchaser may notify Seller through email.

 

3. CLOSING. The
purchase and sale of the Shares shall take place on or before January 13, 2017; at or before 11 PM EST (which time is designated
as the “Closing”). At Closing, Purchaser shall deliver to Seller, in cash, by wire transfer to an account to be designated
by Seller, or his nominee for the Purchase Price totaling the amount of One Hundred Thousand U.S. dollars and no cents ($100,000.00),
which amount shall include any good faith deposits made, if any, and Seller will promptly deliver the following to Purchaser: (A)
the certificates representing the Shares transferred hereunder, duly endorsed for transfer to the Purchaser or accompanied by appropriate
stock powers, (B) the original of the Certificate of Incorporation and bylaws, (C) all corporate books and records; (D) written
resignations of incumbent directors and officers of the Corporation; and (F) an affidavit certifying that all liabilities of the
Corporation prior to the Closing date shall be paid in full out of the proceeds of this share purchase.

 

4. POST-CLOSING
DUTIES BY SELLER. Seller agrees to perform following duties for Purchaser after

the Closing for
no additional fee:

 

a. Completion of
year end audit for fiscal year ending 11-30-16. Seller will prepare and file Form 10-K. Seller will pay for audit and 10-K.

b. Post-effective amendment
to the registration statement upon business combination with Photozou Co, Ltd. pursuant to the terms and conditions of Rule 419
offering.

 c. 8-K filing
for the sale of common stock by Seller.

d. Resignation of
current director and appointment of new director.

e. Schedule 14F
& Schedule 13D filing.

f. Introduction
to PCAOB auditor.

g. Introduction
to our Rule 419 Escrow Agent

h. Introduction
to stock Transfer Agent

i. Form 3. 

j. Consult with
market maker to file FINRA Form 211.

k. Consult with
DTC market participant so shares may be electronically traded. Purchaser will pay DTC market participant.

l. Company name
change.

 

 5. REPRESENTATIONS
AND WARRANTIES OF SELLER. Seller, as sole director and officer of Corporation, hereby represents and warrants to Purchaser
that:

 

		(i)	Corporation is a blank check corporation duly organized and validly
existing and in good standing under the laws of the State of Delaware and has the corporate power and authority to carry on the
business it is now being conducted. Corporation and/or Seller do not require any consent and/or authorization, declaration or filing
with any government or regulatory authority to undertake any actions herein;

 

		(ii)	Corporation has filed with the United States Securities and Exchange
Commission (‘SEC”) a registration statement on Form S-1 in accordance with 17 CFR 230.419, as amended. The effective
date of registration statement is August 19, 2016. 

 

		(iii)	Corporation has timely filed and is current on all reports required
to be filed by it pursuant to Sections 13 and 15 of the Securities Exchange Act of 1934.

 

		(iv)	Corporation was formed in Delaware on September 29, 2014 with no
financial information available other than the financial information included in its SEC filings; 

 

		(v)	There are no legal actions, suits, arbitrations, or other administrative,
legal or governmental proceedings threatened or pending against the Corporation and/or Seller or against the Seller or other employee,
officer, director or stockholder of Corporation. Additionally, Seller is not aware of any facts which may/might result in or form
a basis of such action, suit, arbitration or other proceeding on any basis whatsoever; 

 

		(vi)	The Corporation has no subsidiaries or any direct or indirect ownership
interest in any other corporation, partnership, association, firm or business in any manner;

 

		(vii)	The Corporation and/or Seller does not have in effect nor has any
present intention to put into effect any employment agreements, deferred compensation, pension retirement agreements or arrangements,
options arrangements, bonus, stock purchase agreements, incentive or profit–sharing plans; 

 

		(viii)	No person or firm has, or will have, any right, interest or valid
claim against the Corporation for any commission, fee or other compensation in connection with the sale of the Shares herein as
a finder or broker or in any similar capacity as a result of any act or omission by the Corporation and/or Seller or anyone acting
on behalf of the Corporation and/or Seller;

 

		(ix)	The business and operation of the Corporation has and will be conducted
in accordance with all applicable laws, rules, regulations, judgments. Neither the execution, delivery or performance of this Agreement
(A) violates the Corporation’s by-laws, Certificate of Incorporation, Shareholder Agreements or any existing resolutions;
and, (B) will cause the Corporation to lose any benefit or any right or privilege it enjoys under the Securities Act (“Act”)
or other applicable state securities laws; 

 

		(x)	Corporation has not conducted any business and/or entered into any
agreements with third-parties other than Amended and Restated Subscription Escrow Agreement with Wilmington Trust, National Association,
as escrow agent for the S-1 blank check offering whereas the foregoing escrow agreement is attached as Exhibit 99.1 to the S-1/A
registration statement on August 12, 2016; 

 

		(xi)	This Agreement has been duly executed and delivered by Seller constitutes
a valid and binding instrument, enforceable in accordance with its terms and does not conflict with or result in a breach of or
in violation of the terms, conditions or provisions of any agreement, mortgage, lease or other instrument or indenture to which
Corporation and/or Seller a party or by which they are bound;

 

		(xii)	Seller is the legal and beneficial owner of the Shares and has good
and marketable title thereto, free and clear of any liens, claims, rights and encumbrances;

 

		(xiii)	Seller warrants that the Corporation being transferred shall be transferred
with no liabilities and little or no assets, and shall defend and hold Purchaser and the Corporation harmless against any action
by any third party against either of them arising out of, or as a consequence of, any act or omission of Seller or the Corporation
prior to, or during the closing contemplated by this contract of sale; and

 

		(xiv)	Seller will cause all current officers and directors of the Corporation
to resign at the Closing.

 

		(xv)	This Agreement is not contingent on the sale of any S-1 registered
shares of the Corporation to any person or entity. 

  

6. REPRESENTATIONS
AND WARRANTIES OF PURCHASER. Purchaser hereby represents

and warrants to
Seller that:

 

		(i)	Purchaser has the power and authority to execute and deliver this
Agreement, to perform his obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been
duly executed and delivered by Purchaser and constitutes a valid and binding instrument, enforceable in accordance with its terms;

 

		(ii)	The execution, delivery and performance of this Agreement is in compliance
with and does not conflict with or result in a breach of or in violation of the terms, conditions or provisions of any agreement,
mortgage, lease or other instrument or indenture to which Purchaser is a party or by which Purchaser is bound;

 

		(iii)	At no time was Purchaser presented with or solicited by or through
any leaflet, public promotional meeting, television advertisement or any other form of general solicitation or advertising; and,

 

(iv) Purchaser
is purchasing the Shares solely for its own account for the purpose of investment and not with a view to, or for sale in connection
with, any distribution of any portion thereof in violation of any applicable securities law.

 

(v) The
Purchaser is an "accredited investor" as defined under Rule 501 under the Securities Act.

 

(vi) Purchaser
hereby understands that the foregoing shares purchased from Seller are restricted securities and not registered in the S-1 registration
statement and being sold pursuant to available exemption under the Act.

 

(vii) Purchaser
acknowledges that the Company is a blank check company and that the Company has filed an S-1 registration statement, File No. 333-201697
whereas the Company is subject to the rules and conditions of 17 CFR 230.419.

 

(viii)
Purchaser acknowledges their understanding of 17 CFR 230.419.

 

(ix) Purchase
has received and reviewed the prospectus and registration statement of the Corporation.

 

(x) The Purchaser acknowledges
that Seller’s restricted shares are not part of the Rule 419 S-1 offering

statement and therefore
are exempt from the terms and conditions of the foregoing Rule.

 

(xi) The Purchaser
acknowledges that the Corporation agrees to notify escrow agent when it has filed a

post-effective
amendment for acquisition agreement whereas, it has filed executed agreement(s) for

the acquisitions
of business(es) or assets that constitute the business (or a line of business) of the

Corporation and
for which the fair value of the business(es) or net assets to be acquired represents

at least 80 percent
of the maximum offering proceeds including proceeds received or to be received

upon the exercise
or conversion of any securities offered, but excluding amounts payable to non-

affiliates for
underwriting commissions, underwriting expenses and dealer allowances.

 

7. NOTICES.
Notice shall be given by email at the most recent address last received by Seller from Buyer or by Buyer from Seller. Notice
may also be given by certified mail, return receipt requested, the date of notice being deemed the date of postmarking. Notice,
unless either party has notified the other of an alternative address as provided hereunder, shall be sent to the address as set
forth herein:

 

Seller:

 

Thomas DeNunzio,
President and Director

Exquisite Acquisition,
Inc.

780 Reservoir Avenue,
#123

Cranston, R.I. 02910

Phone: (401) 641-0405

FAX: (401) 633-7300

Email: tom@vfinancialgroup.com

 

Purchaser:

 

Photozou Co., Ltd

2-24-13-904, Kamiosaki,
Shinagawa-ku

Tokyo, 141-0021

 

8. GOVERNING
LAW. This Agreement shall be interpreted and governed in accordance with the laws of the State of Rhode Island. The parties
herein waive trial by jury. In the event that litigation results or arise out of this Agreement or the performance thereof, the
parties agree that the prevailing party is entitled to reimbursement for the non-prevailing party of reasonable attorney’s
fee, costs, expenses, in addition to any other relief to which the prevailing party may be entitled.

 

9. CONDITIONS
TO CLOSING. The Closing is conditioned upon the fulfillment by the Seller of the satisfaction of the representations and warranties
made herein being true and correct in all material respects as of the date of Closing.

 

10. SEVERABILITY.
In the event that any term, covenant, condition, or other provision contained herein is held to be invalid, void or otherwise unenforceable
by any court of competent jurisdiction, the invalidity of any such term, covenant, condition, provision or Agreement shall in no
way affect any other term, covenant, condition or provision or Agreement contained herein, which shall remain in full force and
effect.

 

11. ENTIRE AGREEMENT.
This Agreement contains all of the terms agreed upon by the parties with respect to the subject matter hereof. This Agreement has
been entered into after full investigation.

 

12. INVALIDITY.
If any paragraph of this Agreement shall be held or declared to be void, invalid or illegal, for any reason, by any court of competent
jurisdiction, such provision shall be ineffective but shall not in any way invalidate or effect any other clause, Paragraph, section
or part of this Agreement.

 

13. GENDER AND
NUMBER; SECTION HEADINGS. Words importing a particular gender mean and include the other gender and words importing a singular
number mean and include the plural number and vice versa, unless the context clearly indicated to the contrary. The section and
other headings contained in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of
this Agreement.

 

14. AMENDMENTS.
No amendments or additions to this Agreement shall be binding unless in writing, signed by both parties, except as herein otherwise
provided.

 

15. ASSIGNMENT.
Neither party may assign this Agreement without the express written consent of the other party. Any agreed assignment by the Seller
shall be effectuated by all the necessary corporate authorizations and governmental and/or regulatory filings.

 

16. CLOSING DOCUMENTS.
Seller and Purchaser agree, at any time, to execute, and acknowledge where appropriate, and to deliver any and all documents/instruments,
and take such further action, which may necessary to carry out the terms, conditions, purpose and intentions of this Agreement.
This paragraph shall survive the Closing.

 

17. EXCLUSIVE
AGREEMENT; AMENDMENT. This Agreement supersedes all prior agreements or understandings among the parties with respect to its
subject matter with respect thereto and cannot be changed or terminated orally.

 

18. FACSIMILE
SIGNATURES. Execution of this Agreement and delivery of signed copies thereof by facsimile signatures from the parties hereto
or their agents is acceptable to the parties who waive any objections or defenses based upon lack of an original signature.

 

19. PUBLICITY.
Except as otherwise required by law, none of the parties hereto shall issue any press release or make any other public statement,
in each case relating to, connected with or arising out of this Agreement or the matters contained herein, without obtaining the
prior approval of the other to the contents and the manner of presentation and publication thereof.

 

20. INDEMNIFICATION.
Seller shall hold Purchaser harmless from any and all claims arising out of or related to (i) actions taken by Seller in her capacity
as a shareholder of the Company prior to the payment of the good faith deposit, or (ii) any lawsuits against the Corporation arising
during the period of time prior to the payment of the good faith deposit; (iii) any requests, audits or comment letters issued
by the Securities and Exchange Commission related to the period of time prior to receipt of the good faith deposit. 

 

 

IN WITNESS WHEREOF,
and intending to be legally bound, the parties hereto have carefully read the foregoing Agreement and fully understand its contents
and binding effect. This Agreement shall become effective upon signature of Purchaser and Seller at the date first written above.

 

 

 

By: /s/ Koichi
Ishizuka 

  PURCHASER: Photozou Co., Ltd. by

Koichi Ishizuka, its chief executive officer

 

 

By: /s/ Thomas DeNunzio

SELLER: Thomas DeNunzio

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]